Basic info
Industry
biotechnology research
Sectors
targeted therapy
Biotechnology
blood disorders
genomically defined cancers
drug design
Precision therapy
systemic mastocytosis
oncology
lung cancer
rare diseases
hematology
Health Care
cancer immunotherapy
molecular targeting
Medical
Bioinformatics
Date founded
2011
Funding rounds raised
Total raised
$1.3B
from 16 investors over 16 rounds
B
Blueprint Medicines raised $1.3B on June 30, 2022
Investors: Royalty Pharma and Sixth Street
B
Blueprint Medicines raised $50M on November 12, 2014
Investors: Nextech Invest, -, Tavistock Group, Wellington Management, Perceptive Advisors, Redmile Group, RA Capital Management, L.P. and Third Rock Ventures
B
Blueprint Medicines raised $25M on January 7, 2014
Investors: Nextech Invest, Third Rock Ventures, Casdin Capital, LLC and F-Prime Capital Partners
B
Blueprint Medicines raised $40M on April 11, 2011
Investors: Third Rock Ventures and F-Prime Capital Partners